Sartorius sets up international scholarship programme
Sartorius sets up international scholarship programme
Sartorius AG has set up a new international scholarship program, "Sartorius International Biosciences Scholarship." It offers final year students and those who have already earned a degree in the natural sciences and/or technology and who would like to gain experience working at a German technology group. In particular, the program addresses scientific junior employees from the global growth regions, such as Asia, Eastern Europe and Latin America. Integrated into global teams, the scholarship program participants will work on selected projects in R&D as well as product marketing in the Biotechnology Division.
Within the scope of the scholarship program, Sartorius will be initially offering ten positions. Already, the company trains around 30 interns at its German locations, in addition to offering multiyear vocational training programs to approximately 90 young employees.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
